Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab based concurrent bioradiotherapy in high risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial
The prognosis of advanced oral squamous cell carcinoma is poor. We investigated the effect of cetuximab based sequential therapy as a primary treatment.
Head neck